Product NDC: | 0173-0809 |
Proprietary Name: | JALYN |
Non Proprietary Name: | dutasteride and tamsulosin hydrochloride |
Active Ingredient(s): | .5; .4 mg/1; mg/1 & nbsp; dutasteride and tamsulosin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0809 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022460 |
Marketing Category: | NDA |
Start Marketing Date: | 20100621 |
Package NDC: | 0173-0809-59 |
Package Description: | 90 CAPSULE in 1 BOTTLE (0173-0809-59) |
NDC Code | 0173-0809-59 |
Proprietary Name | JALYN |
Package Description | 90 CAPSULE in 1 BOTTLE (0173-0809-59) |
Product NDC | 0173-0809 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dutasteride and tamsulosin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100621 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
Strength Number | .5; .4 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |